Akèy › Miasteni grav › Oregon › Portland
Etid klinik pou Miasteni grav nan Portland, OR
6 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Ap rekriteFaz 2
- University of Oregon, Portland
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Ap rekriteFaz 1/2
- Oregon Health & Science University, Portland
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Ap rekriteFaz 2/3
- Oregon Health & Science University, Portland
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Ap rekriteFaz 1
- Oregon Health & Science University (OHSU), Portland
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Ap rekriteEtid obsèvasyon
- Oregon Health and Science University, Portland
- University of Colorado Hospital, Portland
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
Ap rekriteVolontè an sante akeyi
- OHSU, Portland
Etid Miasteni grav nan lòt vil
- Tampa, FL12 etid
- Houston, TX11 etid
- Durham, NC10 etid
- Boca Raton, FL10 etid
- Columbus, OH8 etid
- Miami, FL7 etid
- New York City, NY7 etid
- Milwaukee, WI7 etid
- St. Louis, MO7 etid
- Boston, MA6 etid
- Washington, DC6 etid
- San Francisco, CA6 etid
Lòt etid nan Portland
- Kansè Poumon ki pa ti selil46 etid
- Kansè (tout kalite)34 etid
- Kansè nan tete33 etid
- Kansè pwostat33 etid
- Kansè Metastatik29 etid
- Kansè kolorektal28 etid
- Kansè ovè27 etid
- Kansè poumon26 etid
- Leksemi mieloïd egi25 etid
- Kansè Endomèt24 etid
- Karsinòm selil skuamèz tèt ak kou19 etid
- Kansè pankreyas19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.